Browse news and stories about ARC Oxford (previously Oxford Business Park) – a science and innovation cluster and home to a thriving community of world-changing companies on the edge of Oxford city.
OMass Therapeutics, a biotechnology company at ARC Oxford identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, has announced the appointment of Melissa Faris as Chief Business Officer.
Breakthrough Properties has held groundbreaking events in October to herald the start of the construction of Trinity House by Breakthrough in one of the leading academic and innovation clusters in Oxford.
Led by Blue Venture Fund, the new funding will accelerate Oxford-based Ultromics’ use of AI-enabled echocardiograms to improve patient outcomes.